NEW YORK, June 27, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
This is a detailed report on the biopharmaceuticals market in India. India has emerged as one of the most potential biotech destinations of the world. In fact, biotechnology is the new IT of India. There is a clear consensus among the people in that biotechnology has the potential to create a revolution in the field of agriculture, industrial and service production. This enthusiasm and drive has resulted in the Indian biotech market reaching INR 14,199 crore in 2009-10.
By segment, biopharmaceuticals dominate the biotechnology market. India is the home to more than 130 biopharmaceutical companies, many of which are fully integrated. These companies account for around 70% of the total biotech market.
Biopharmaceutical sector has shown dramatic growth over the past few years, with the overall market reaching Rs. 6543 crore in 2008-09, thanks to a fast-growing economy, large population and intellectual property-supportive regime. And as domestic demand for better healthcare increases and international opportunities for biologics rise, India will continue to expand its presence on the world biopharmaceutical stage.
Science of Biopharmaceuticals
Pharmaceuticals, Biotechnology and Biopharmaceuticals
Push Factors for the Market
Market by Segment
Analysis of Emerging Areas
Contract Research and Outsourcing
Collaborations and Alliances
Serum Institute of India
Shantha Biotechnics Ltd
To order this report:
Intl: +1 805-652-2626
Copyright©2010 PR Newswire.
All rights reserved